• Теги
    • избранные теги
    • Компании973
      • Показать ещё
      • Показать ещё
      Страны / Регионы265
      • Показать ещё
      Международные организации21
      • Показать ещё
      • Показать ещё
      • Показать ещё
Выбор редакции
08 сентября, 18:38

Epizyme Non-Hodgkin Lymphoma Drug Clears Futility Hurdle

Epizyme, Inc. (EPZM) reported that an Independent Data Monitoring Committee had convened earlier this week to assess the futility of its lead candidate tazemetostat for the treatment of follicular lymphoma.

07 сентября, 22:44

Exelixis Reports Interim Analysis of Liver Cancer Trial Data

Exelixis, Inc. (EXEL) announced the outcome from the first planned interim analysis of a randomized phase III trial, CELESTIAL, on cabozantinib.

07 сентября, 17:56

Dynavax Rebounds on Same PDUFA Date for Heplisav BLA

Shares of Dynavax Technologies Corporation (DVAX) bounced back after the company indicated that the FDA will review its BLA for experimental hepatitis B vaccine, Heplisav on the current Prescription Drug User Fee Act (PDUFA) date of Dec 15, 2016.

Выбор редакции
07 сентября, 17:21

HCA Holdings Boosts Patient Care; to Buy Mobile Heartbeat

HCA Holdings Inc. (HCA) recently inked a deal to buy Mobile Heartbeat for an undisclosed amount.

Выбор редакции
02 сентября, 15:45

Why Actelion (ALIOF) Isn't Done Growing Earnings Yet

One company that might be well-positioned for future earnings growth is Actelion Ltd. (ALIOF)

01 сентября, 15:42

Pfizer's Lung Cancer Drug Xalkori Label Expanded in the EU

Pfizer, Inc. (PFE) announced that its lung cancer drug Xalkori has been approved for an additional indication by the European Commission (EC).

31 августа, 18:28

Array (ARRY) Presents Positive Cardiovascular Trial Data

Array BioPharma (ARRY) presented positive results from a phase II study on its pipeline candidate, ARRY-797, at the European Society of Cardiology Congress 2016 in Rome, Italy.

31 августа, 17:00

Express Scripts' New Program to Lower Diabetes Care Costs

Express Scripts Holding Company (ESRX) has launched the Diabetes Care Value Program to lower costs for patients and provide better care.

31 августа, 15:59

Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel

Novartis (NVS) received a major boost when its generic arm, Sandoz obtained FDA approval for Erelzi, the biosimilar version of Amgen???s blockbuster drug Enbrel (etanercept).

Выбор редакции
30 августа, 17:03

Amgen (AMGN) Reports Positive Data on Prolia and Repatha

Amgen announced positive data on Prolia and Repatha from late stage studies.

Выбор редакции
29 августа, 15:38

Abbott Labs Sued by Alere over Pending $5.8B Acquisition

Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.

26 августа, 22:23

Illumina Keen on Genome Network Growth & Global Expansion

On Aug 25, 2016, we issued an updated research report on Illumina Inc. (ILMN).

Выбор редакции
26 августа, 16:00

Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt

Shares of Vanda Pharmaceuticals (VNDA) surged 20.6% after the U.S. District of Delaware ruled in favor of the company in a patent infringement lawsuit against Roxane Laboratories

25 августа, 15:28

Amgen Gets CRL for Secondary Hyperparathyroidism Drug

Amgen (AMGN) announced that the FDA has issued a Complete Response Letter from for its New Drug Application (NDA) for Parsabiv.

24 августа, 14:14

Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business

Pfizer (PFE) entered into an agreement to acquire the rights to AstraZeneca's (AZN) late-stage small-molecule anti-infectives business in the ex-U.S. markets.

24 августа, 13:48

Clovis (CLVS) Stock Up on FDA Priority Review for Rucaparib

The FDA will respond on the approval status of rucaparib by Feb 23, 2017.

23 августа, 16:43

Galapagos (GLPG) Advances RA Drug Filgotinib to Phase III

Galapagos (GLPG) announced the initiation of a phase III program on filgotinib for the treatment of patients with rheumatoid arthritis.

23 августа, 16:37

Puma (PBYI) Neratinib's Application Validated in EU, Stock Up

Puma (PBYI) announced that its Marketing Authorization Application for neratinib has been validated by the European Medicines Agency.

Выбор редакции
23 августа, 15:59

Eli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track

Eli Lilly (LLY) and AstraZeneca's (AZN) Alzheimer's disease treatment is currently in phase III studies.

23 августа, 11:50

Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)

Pfizer (PFE) is buying cancer-focused Medivation for $14 billion with the deal slated to close in the third or fourth quarter.